Liquid Biopsy Market Report: Trends, Insights, and Forecast for 2030

According to the study by Next Move Strategy Consulting, the Liquid Biopsy Market size is predicted to reach USD 15.21 billion by 2030 with a CAGR of 16.44% till 2030.

Liquid biopsy also known as fluid biopsy or fluid phase biopsy, a non-invasive fast technique, which helps to detect and diagnose a variety of cancers such as lung, liver, breast and others at an early stage.

The procedure of liquid biopsy is conducted by collecting blood samples to investigate different kinds of tumor material that include DNA, RNA and exosomes present in the blood. These tests also provide information on residual tumor cells, therapeutic efficacy and early detection of recurrence.

Request FREE Sample PDF: https://www.nextmsc.com/liquid-biopsy-market/request-sample